ÂÜÀòÂÒÂ×

Greta Preatoni serves as the Chief Executive Officer of MYNERVA, where leadership focuses on developing an innovative device for diabetic neuropathy treatment that incorporates neurostimulation and artificial intelligence. Preatoni is currently a Postdoctoral Researcher at the Eidgenössische Technische Hochschule Zürich, contributing to the treatment of diabetic neuropathy and holding the Bridge Proof of Concept 2023 Fellowship. A significant research background includes a PhD in Neuroengineering from ETH Zürich, with a focus on chronic pain solutions and multisensory integration. Previous roles include Vice President at Financiere Marjos, Ricercatore at Scuola Superiore Sant'Anna studying Parkinson's Disease, and management responsibilities at Preatoni. Preatoni's educational credentials also encompass a Master's degree in Neuroscience and a Bachelor's degree in Psychology.